Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction

James D Flaherty1, Charles J Davidson, David P Faxon

  • 1Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. j-flaherty2@md.northwestern.edu

Insights

Early revascularization after myocardial infarction (MI) improves survival and left ventricular function. Procedures like percutaneous coronary intervention and bypass surgery are compared to thrombolytic therapy for post-MI patients at risk of heart failure.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Medicine

Background:

  • Myocardial infarction (MI) survivors face high risks of left ventricular dysfunction (LVD), heart failure, and mortality.
  • Left ventricular function impairment post-MI significantly increases adverse outcomes and mortality risk.

Purpose of the Study:

  • To evaluate the impact of early coronary revascularization on survival and left ventricular function in post-MI patients.
  • To compare percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery with thrombolytic therapy for managing post-MI LVD.
  • To review rescue revascularization strategies and emerging interventional techniques for post-MI LVD.

Main Methods:

  • Comparative analysis of primary and nonemergent percutaneous coronary revascularization versus thrombolytic therapy.
  • Review of outcomes including survival, left ventricular function, and complications (recurrent MI, stroke).
  • Description of rescue revascularization and advanced techniques like ventricular assist devices and bioabsorbable stents.

Main Results:

  • Early revascularization plays a crucial role in preserving and restoring left ventricular function after MI.
  • Percutaneous coronary intervention and CABG surgery demonstrate specific effects on survival and complications compared to thrombolysis.
  • Rescue revascularization is indicated for specific patient subsets failing initial therapy or presenting late.

Conclusions:

  • Coronary revascularization is vital for improving outcomes in patients with post-MI left ventricular dysfunction.
  • Advanced interventional techniques show promise but require further clinical validation.
  • Timely and appropriate revascularization strategies are key to reducing mortality and morbidity in MI survivors.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...